500672 On Other Exchanges
Symbol
Exchange
500672 is not on other exchanges.

novartis india ltd (500672) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NOVARTIS INDIA LTD (500672)

Related News

No related news articles were found.

novartis india ltd (500672) Related Businessweek News

No Related Businessweek News Found

novartis india ltd (500672) Details

Novartis India Limited manufactures and sells healthcare products in India and internationally. It operates through four segments: Pharmaceuticals, Generics, Over-The-Counter, and Animal Health. The Pharmaceuticals segment offers a portfolio of prescription medicines through healthcare professionals. The Generics segment provides retail generics products in various therapeutic areas, such as anti-TB, anti-DUB (gynecology), anti-histamines, antibiotics, anti-ulcerants, anti-diabetes, and cardiovascular. The Over-The-Counter segment offers vitamins, minerals, and nutritional supplements, as well as products for the treatment of cough, cold, and allergy. The Animal Health segment provides products for the cattle and poultry markets. The company was founded in 1947 and is based in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.

752 Employees
Last Reported Date: 07/5/16
Founded in 1947

novartis india ltd (500672) Top Compensated Officers

Vice Chairman, Managing Director, Chairman of...
Total Annual Compensation: 14.5M
Chief Financial Officer and Whole-Time Direct...
Total Annual Compensation: 12.0M
Compliance Officer and Company Secretary
Total Annual Compensation: 7.0M
Executive Officer
Total Annual Compensation: --
Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2016.

novartis india ltd (500672) Key Developments

Novartis India Ltd. Announces Resignation of Girish Tekchandani as Company Secretary & Compliance Officer, Effective August 12, 2016

Novartis India Ltd. announced that the board of directors of the company at its meeting held on July 28, 2016 noted and approved resignation of Mr. Girish Tekchandani as Company Secretary & Compliance Officer effective close of business hours on August 12, 2016.

Novartis India Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2016

Novartis India Limited announced unaudited standalone earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported revenue from operations of INR 1,586.2 million against INR 2,148.3 million a year ago. Profit from operations before other income and finance costs was INR 85.4 million against INR 0.2 million a year ago. Profit before tax was INR 297.2 million against INR 203.7 million a year ago. Net profit was INR 190.7 million against INR 133.4 million a year ago. Basic and diluted earnings per share were INR 5.97 against INR 4.17 a year ago.

Novartis India Limited to Report Q1, 2017 Results on Jul 28, 2016

Novartis India Limited announced that they will report Q1, 2017 results on Jul 28, 2016

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

500672 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 500672.
View Industry Companies
 

Industry Analysis

500672

Industry Average

Valuation 500672 Industry Range
Price/Earnings 10.9x
Price/Sales 3.2x
Price/Book 2.0x
Price/Cash Flow 11.0x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NOVARTIS INDIA LTD, please visit www.novartis.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.